These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 29550533

  • 1. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
    El-Nagar MKS, Abdu-Allah HHM, Salem OIA, Kafafy AN, Farghaly HSM.
    Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
    Chaaban I, Rizk OH, Ibrahim TM, Henen SS, El-Khawass EM, Bayad AE, El-Ashmawy IM, Nematalla HA.
    Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
    [Abstract] [Full Text] [Related]

  • 3. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
    El-Miligy MMM, Hazzaa AA, El-Messmary H, Nassra RA, El-Hawash SAM.
    Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
    [Abstract] [Full Text] [Related]

  • 4. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA, Labib MB, Abdel-Latif M.
    Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
    [Abstract] [Full Text] [Related]

  • 5. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
    El-Miligy MM, Hazzaa AA, El-Messmary H, Nassra RA, El-Hawash SA.
    Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN, Chen QH, Knaus EE.
    J Med Chem; 2006 Mar 09; 49(5):1668-83. PubMed ID: 16509583
    [Abstract] [Full Text] [Related]

  • 7. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM, Abdelmoez AAB, Tarazi H, El-Shorbagi AA, El-Awady R.
    Bioorg Chem; 2020 Jan 09; 94():103378. PubMed ID: 31677858
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
    Abdelgawad MA, Labib MB, Ali WAM, Kamel G, Azouz AA, El-Nahass ES.
    Bioorg Chem; 2018 Aug 09; 78():103-114. PubMed ID: 29550530
    [Abstract] [Full Text] [Related]

  • 9. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT, Abou-Ghadir OMF, Abdel-Moty SG, Ali AY, Salem OIA.
    Bioorg Med Chem; 2020 Apr 01; 28(7):115403. PubMed ID: 32127262
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A.
    Bioorg Med Chem; 2017 Aug 15; 25(16):4424-4432. PubMed ID: 28669741
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF, Philoppes JN, Rárová L.
    Arch Pharm (Weinheim); 2018 Apr 15; 351(3-4):e1700311. PubMed ID: 29400411
    [Abstract] [Full Text] [Related]

  • 12. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA, Abdelall EKA, Elshemy HAH, El-Nahass ES, Abdel-Fattah MM, Abdelgawad YYM.
    Arch Pharm (Weinheim); 2021 Apr 15; 354(4):e2000328. PubMed ID: 33314237
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
    Abdelrahman MH, Youssif BGM, Abdelgawad MA, Abdelazeem AH, Ibrahim HM, Moustafa AEGA, Treamblu L, Bukhari SNA.
    Eur J Med Chem; 2017 Feb 15; 127():972-985. PubMed ID: 27837994
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
    Huang Y, Zhang B, Li J, Liu H, Zhang Y, Yang Z, Liu W.
    Eur J Med Chem; 2019 Oct 15; 180():41-50. PubMed ID: 31299586
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase.
    Shabaan MA, Kamal AM, Faggal SI, Elsahar AE, Mohamed KO.
    Arch Pharm (Weinheim); 2020 Apr 15; 353(4):e1900308. PubMed ID: 32031284
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM, Abdu-Allah HHM, Abdel-Moty SG.
    Bioorg Chem; 2018 Oct 15; 80():461-471. PubMed ID: 29986191
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.
    Gedawy EM, Kassab AE, El Kerdawy AM.
    Eur J Med Chem; 2020 Mar 01; 189():112066. PubMed ID: 31982653
    [Abstract] [Full Text] [Related]

  • 18. Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
    Moussa G, Alaaeddine R, Alaeddine LM, Nassra R, Belal ASF, Ismail A, El-Yazbi AF, Abdel-Ghany YS, Hazzaa A.
    Eur J Med Chem; 2018 Jan 20; 144():635-650. PubMed ID: 29289887
    [Abstract] [Full Text] [Related]

  • 19. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF, Ali WAM, Bazgier V, Rárová L.
    Eur J Med Chem; 2016 Nov 10; 123():803-813. PubMed ID: 27541263
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors.
    Shaaban MA, Kamal AM, Faggal SI, Farag NA, Aborehab NM, Elsahar AE, Mohamed KO.
    Arch Pharm (Weinheim); 2020 Nov 10; 353(11):e2000027. PubMed ID: 32696514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.